| Log in

Glenmark Mops Up Rs 413cr Via QIP

15 September, 2009

Drug maker Glenmark Pharmaceuticals Ltd has raised Rs 413 crore through the qualified institutional placement (QIP) route, according to its filing with the BSE. The company will deploy these funds to reduce its debt burden, which currently stands at Rs 2,000 crore. 

A little over 1.87 crore shares have been placed with the investors at Rs 221 each. Enam Securities and Citigroup were the bankers to the deal.

The share price of Glenmark closed at Rs 216.8 today, up by less than 1%, against the Sensex which was up by around 1.5%.

Glenmark has also said that it plans to sell stake in Glenmark Generics, a generic and active pharmaceutical ingredients (API) manufacturer which is a 100% subsidiary of the firm. According to a report from Moneycontrol, these funds would also go towards debt repayment. Glenmark Generics posted net sales of $196 million in FY 2008, according to the company website.


Leave Your Comment
Glenmark Generics To Raise Rs 575 Cr Via IPO

Glenmark Generics To Raise Rs 575 Cr Via IPO

TEAM VCC 8 years ago
Glenmark Generics Ltd (GGL), a subsidiary of Mumbai-based Glenmark...
Temasek to invest $151M in Glenmark Pharma

Temasek to invest $151M in Glenmark Pharma

TEAM VCC 3 years ago
Glenmark Pharmaceuticals Ltd is raising Rs 945 crore ($151 million) through a...
IFC to anchor Glenmark's $200 mn fundraising plan

IFC to anchor Glenmark’s $200 mn fundraising plan

Anuradha Verma 1 year ago
International Finance Corp (IFC) is looking to invest up to $75 million (about...
No Comments

Glenmark Mops Up Rs 413cr Via QIP

Powered by WordPress.com VIP